Physician profile
Robert D Connors
NPI 1801030473
$1,226.38
in general payments reported to CMS, 2019-2025
22 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $30.95 · 2021: $210 · 2022: $203 · 2023: $181 · 2024: $323 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $169.88 | 2021-2025 | Emgality, Reyvow, Kisunla |
| Lundbeck LLC | $142.77 | 2022-2025 | Vyepti |
| Sk Life Science, INC. | $108.43 | 2021-2025 | |
| Medtronic USA, INC. | $92.02 | 2019 | |
| Supernus Pharmaceuticals, INC. | $88.48 | 2021-2025 | Qelbree |
| Abbvie INC. | $81.62 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $75.40 | 2019-2021 | |
| Pfizer INC. | $62.44 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.04 | 2022 | |
| Argenx US, INC. | $48.07 | 2024-2025 | Vyvgart Hytrulo |
| Jazz Pharmaceuticals INC. | $42.65 | 2023-2024 | Epidiolex |
| Greenwich Biosciences, INC. | $40.64 | 2020-2021 | |
| Genentech USA, INC. | $29.39 | 2022-2023 | Evrysdi |
| Amylyx Pharmaceuticals, INC. | $28.87 | 2023-2024 | Relyvrio |
| Neuropace, INC. | $25.31 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $24.24 | 2023 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $22.67 | 2021 | |
| Ucb, INC. | $21.16 | 2024 | Briviact |
| Philips North America LLC | $20.88 | 2024 | (Ak6) Vest Therapy |
| Aucta Pharmaceuticals, INC. | $15.21 | 2025 | Motpoly Xr |
| Biohaven Pharmaceuticals, INC. | $15.00 | 2021 | |
| Csl Behring | $13.21 | 2024 | Hizentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Connors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.